Infectious Mononucleosis
Recent clinical, regulatory, research and industry developments relating to this disease.
Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
Epstein-Barr virus: the mastermind of immune chaos.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q4 2027.
Clinical MilestonesViewHide
- 2026-05-18ClinicalPhase 1 Study of the Safety of an Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV InfectionResults expected Q4 2027
- 2026-04-20ClinicalA Phase 1/2 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-Seronegative PersonsCompleted
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Epstein-Barr Virus Infections2
- Antibodies, Viral1
- Herpesvirus 4, Human1
- Infectious Mononucleosis1
Leading journals2
- Frontiers in immunology1
- PLoS pathogens1
Leading researchers8
- Alves CEC1
- Brooks JM1
- Croom-Carter D1
- Douglas MR1
- Haigh TA1
- Leese A1
- Pontes GS1
- Rickinson A1
Affiliations (unnormalised)6
- Dudley Group of Hospitals NHS Foundation Trust1
- Institute of Biological Science1
- Institute of Cancer and Genomic Sciences1
- Institute of Immunology and Immunotherapy1
- Institute of Inflammation and Ageing1
- Laboratory of Virology and Immunology1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
A common, acute infection usually caused by the Epstein-Barr virus (HERPESVIRUS 4, HUMAN). There is an increase in mononuclear white blood cells and other atypical lymphocytes, generalized lymphadenopathy, splenomegaly, and occasionally hepatomegaly with hepatitis.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.